Michael Dacks founded Midatadin.com Ltd. and Type 2 Ventures Ltd. Currently, Mr. Dacks occupies the position of President at Type 2 Ventures Ltd., President & Chief Operating Officer for Psyence Therapeutics Corp. and Chief Operating Officer at Psyence Group, Inc.
He is also on the board of Harborside, Inc.
In the past he held the position of Senior Vice President-Global Affairs at Plena Global Holdings, Inc. and VP-Legal & International Business Affair at MedReleaf Corp.
He received an undergraduate degree from the University of Western Ontario and a graduate degree from Osgoode Hall Law School.